https://fisogatinibinhibitor.c....om/civilized-paroxys
In the multivariate analyses, using CLAG or FLAG regimen as a re-induction chemotherapy regimen, age less then 39 years and SWOG low-risk had been dramatically involving higher remission rates in patients with induction failure. Male, additional AML, SWOG high-risk, the period from the very first remission to relapse within one year, and bone marrow blasts ≥20% during the time of relapse had been somewhat associated with reduced remission prices in relapsed patien
Like
Comment
Share
